Peter Rossing: Clinical Trials

2 trials sponsored by Peter Rossing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Completed 1

Follow Peter Rossing: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Kerendia (Finerenone, BAY94-8862), Placebo - Cardiovascular Autonomic Neuropathy, Type 2 Diabetes
Phase 2RecruitingPeter Rossing1002025-05-022025-05-25
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Spironolactone, Placebo, Standard care - Diabetic Nephropathy, Diabetic Retinopathy
Phase 2 / Phase 3CompletedPeter Rossing17772014-03-012018-12-21

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Nephropathies (1)  ·  Diabetic Neuropathies (1)  ·  Diabetic Retinopathy (1)  ·  Renal Insufficiency, Chronic (1)

Interventions

Spironolactone (1)  ·  Standard of Care (1)  ·  finerenone (1)

Countries

Denmark (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  North Macedonia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Adriaan Kooy, MD (1)  ·  Alberto Ortiz, MD (1)  ·  Andreas Birkenfeld, MD (1)  ·  Christian Delles, MD (1)  ·  Gerjan Navis, MD (1)  ·  Goce Spasovski, MD (1)  ·  Ivan Rychlik, MD (1)  ·  Joachim Beige, MD (1)  ·  Joline Beulens, MD (1)  ·  Marina Noutsou, MD (1)  ·  Marjin Speeckaert, MD (1)  ·  Matias Trillini, MD (1)  ·  Peter Girman, MD (1)

Results publications

PMID 26936907, PMID 29781558, PMID 32135136, PMID 33107592, PMID 36841085, PMID 41130701